Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates

International Journal of Antimicrobial Agents

Volumn 44, Issue 5, 2014, Pages 396-401

  Piewngam, Pipat ^a   Kiratisin, Pattarachai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acinetobacter baumannii; Breakpoint; Colistin; Susceptibility; Tigecycline

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; COLISTIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; ANTIINFECTIVE AGENT; MINOCYCLINE;

ACINETOBACTER BAUMANNII; ANALYTICAL ERROR; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; RELIABILITY; ACINETOBACTER INFECTION; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; DRUG EFFECTS; EVALUATION STUDY; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; REPRODUCIBILITY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; REPRODUCIBILITY OF RESULTS;

EID: 84908450129     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.06.014     Document Type: Article

References (26)

1. N.C. Gordon, and D.W. Wareham Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance Int J Antimicrob Agents 35 2010 219 226
2. H.S. Sader, R.N. Jones, M.G. Stilwell, M.J. Dowzicky, and T.R. Fritsche Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents Diagn Microbiol Infect Dis 52 2005 181 186
3. E. Akinci, I. Mumcuoʇlu, P. Onguru, F.N. Bayazit, S. Ersoy Şen, and A. Erbay In vitro activity of tigecycline against Acinetobacter baumannii strains isolated from nosocomial infections Turk J Med Sci 38 2008 583 586
4. S.Y. Lee, J.H. Shin, K. Lee, M.Y. Joo, K.H. Park, and M.G. Shin Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean university hospital J Clin Microbiol 51 2013 1924 1926
5. T.Y. Tan, and L.S.Y. Ng Comparison of three standardized disc susceptibility testing methods for colistin J Antimicrob Chemother 58 2006 864 867
6. N.C. Gordon, and D.W. Wareham A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline J Antimicrob Chemother 63 2009 775 780
7. A.Y. Tekçe, A. Erbay, H. Çabadak, S. Yaʇci, N. Karabiber, and S. Şen Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report Surg Infect (Larchmt) 12 2011 141 143
8. I.H. Celik, S.S. Oguz, G. Demirel, O. Erdeve, and U. Dilmen Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review Eur J Pediatr 171 2012 311 316
9. N.H. Ahmed, K. Baba, C. Clay, R. Lekalakala, and A.A. Hoosen In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa BMC Res Notes 5 2012 215
10. M.E. Falagas, and D.E. Karageorgopoulos Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology Clin Infect Dis 46 2008 1121 1122
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Document M100-S23. Wayne, PA: CLSI; 2013.
12. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, Version 4.0, 2014. 〈 http://www.eucast.org/clinical-breakpoints ⌠[accessed 09.01.14].
13. R.N. Jones, M.J. Ferraro, L.B. Reller, P.C. Schreckenberger, J.M. Swenson, and H.S. Sader Multicenter studies of tigecycline disc diffusion susceptibility results for Acinetobacter spp J Clin Microbiol 45 2007 227 230
14. Clinical and Laboratory Standards Institute Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline [Document M23-A3] 3rd ed. 2008 CLSI Wayne, PA
15. US Food and Drug Administration Class II special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for industry and FDA 2007 FDA Rockville, MD
16. D.L. Paterson Impact of antibiotic resistance in Gram-negative bacilli on empirical and definitive antibiotic therapy Clin Infect Dis 47 2008 S14 S20
17. M. Kempf, and J.M. Rolain Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options Int J Antimicrob Agents 39 2012 105 114
18. S.S. Jean, and P.R. Hsueh Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens Expert Opin Pharmacother 12 2011 2145 2148
19. A.L. Leal Castro, G. Buitrago Gutierrez, V. Ovalle, J.A. Cortes, C.A. Alvarez Colombian Tigecycline Susceptibility Surveillance Group Comparing in vitro activity of tigecycline by using the disc diffusion test, the manual microdilution method, and the VITEK 2 automated system Rev Argent Microbiol 42 2010 208 211
20. P. Kiratisin, A. Chongthaleong, T.Y. Tan, E. Lagamayo, S. Roberts, and J. Garcia Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study Int J Antimicrob Agents 39 2012 311 316
21. C.M. Pillar, D.C. Draghi, M.J. Dowzicky, and D.F. Sahm In vitro activity of tigecycline against Gram-positive and Gram-negative pathogens as evaluated by BMD and Etest J Clin Microbiol 46 2008 2862 2867
22. A.C. Gales, A.O. Reis, and R.N. Jones Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines J Clin Microbiol 39 2001 183 190
23. J.R. Lo-Ten-Foe, A.M. de Smet, B.M. Diederen, J.A. Kluytmans, and P.H. van Keulen Comparative evaluation of the VITEK 2, disc diffusion, Etest, BMD, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains Antimicrob Agents Chemother 51 2007 3726 3730
24. I. Galani, F. Kontopidou, M. Souli, P.D. Rekatsina, E. Koratzanis, and J. Deliolanis Colistin susceptibility testing by Etest and disc diffusion methods Int J Antimicrob Agents 31 2008 434 439
25. T.Y. Tan, and S.Y. Ng Comparison of Etest, VITEK and agar dilution for susceptibility testing of colistin Clin Microbiol Infect 13 2007 541 544
26. L.A. Arroyo, A. García-Curiel, M.E. Pachón-Ibañez, A.C. Llanos, M. Ruiz, and J. Pachón Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii J Clin Microbiol 43 2005 903 905